Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency - Summary - MDSpire

Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

  • By

  • Natalie J Nokoff

  • Cindy Buchanan

  • Jennifer M Barker

  • January 21, 2025

  • 0 min

Share

Objective:

Emphasize the importance of addressing management challenges.

Key Findings:
  • Add mention of genital differences in 46,XX individuals.
Interpretation:

Specify types of complications requiring ongoing monitoring.

Limitations:
  • Add variability in clinical presentation as a limitation.
Conclusion:

Reiterate the importance of psychosocial support and communication strategies.

Original Source(s)

Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

  • by Natalie J Nokoff, Cindy Buchanan, Jennifer M Barker

  • January 21, 2025

Related Content

Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.

Women Overdue for Cancer Screenings

More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.